Asunto(s)
Colonoscopía/efectos adversos , Cara , Mucosa Intestinal/cirugía , Perforación Intestinal/complicaciones , Cuello , Enfisema Subcutáneo/etiología , Anciano , Colon/cirugía , Femenino , Humanos , Perforación Intestinal/diagnóstico por imagen , Perforación Intestinal/cirugía , Enfisema Mediastínico/diagnóstico por imagen , Enfisema Mediastínico/etiología , Enfisema Mediastínico/cirugía , Neumopericardio/diagnóstico por imagen , Neumopericardio/etiología , Neumopericardio/cirugía , Neumoperitoneo/diagnóstico por imagen , Neumoperitoneo/etiología , Neumoperitoneo/cirugía , Reoperación , Enfisema Subcutáneo/diagnóstico por imagen , Enfisema Subcutáneo/cirugía , Instrumentos Quirúrgicos , Tomografía Computarizada por Rayos XRESUMEN
Hepatitis C virus (HCV) infection represents a substantial risk to both, health care workers and patients. It is of major importance to detect health care workers with HCV infection and to establish regulations how to deal with infected individuals working in specific health care settings. Currently, there are no consistent recommendations, regulations or guidelines concerning prevention of health care worker-to-patient transmission of HCV. Questions arising include: Should health care workers be screened or tested individually on HCV infection and what kind of assay(s) should be used? When and how often should health care workers be tested? How should health care workers with HCV infection be managed? Based on these questions, this article reviews the most relevant published literature. Furthermore, suggestions for establishing a future common regulatory framework are provided.